Phase I Study of Isotretinoin in Patients With Recessive Dystrophic Epidermolysis Bullosa
NCT00014729
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Epidermolysis Bullosa
Interventions
DRUG:
isotretinoin
Sponsor
University of North Carolina